Seq2Know

Seq2Know is a molecular diagnostics company specializing in high-throughput next-generation sequencing (NGS) for infectious disease detection and surveillance. The company operates a CLIA-certified laboratory that provides clinical testing services for respiratory pathogens, including SARS-CoV-2, Influenza, and RSV. Unlike traditional PCR-based methods, Seq2Know's NGS platform allows for the simultaneous detection of multiple pathogens and the identification of specific viral variants. This technology provides critical genomic insights for public health monitoring and clinical decision-making. Founded by researchers from Stanford University, the company aims to make advanced genomic sequencing accessible and scalable for routine diagnostic use.